Close Close

Life Health > Health Insurance > Health Insurance

Malaria vaccine shows early promise in clinical trials

Your article was successfully shared with the contacts you provided.

The novel new vaccine, which involves injecting weakened malarial-inducing parasites into patients in order to elicit a degree of immunity, has been having successful results. The U.S. biotech company, Sanaria, hopes for continued success in order to alleviate the impact of the widespread disease.

More on this topic

Read the story.